Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LOW vs GSK✓SelectedUSD · GSKLOW vs GSK performance historyLatest closeAs of-1.23%11/16
Stock and ETF performance explorer

LOW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+39,286.4%
GSK return
+1,741.1%
Excess return
+37,545.3%
Maximum drawdown
-62.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-0.1%-1.2%-1.2%
7D-3.1%-1.3%-1.8%-2.6%
30D+14.7%+2.7%+11.9%+13.6%
3M+3.6%+2.7%+0.9%+2.5%
6M+4.3%+3.3%+0.9%+2.8%
YTD-4.7%+6.5%-11.1%-7.3%
1Y+0.9%+10.7%-9.8%-3.3%
3Y+18.1%+64.4%-46.2%-4.3%
5Y+1.5%+46.7%-45.2%-15.8%
10Y+305.5%+109.4%+196.1%+193.6%
All+39,286.4%+1,741.1%+37,545.3%+12,540.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling